GRAIL to Present at Jefferies Global Healthcare Conference 2025
GRAIL (NASDAQ: GRAL), a healthcare company focused on early cancer detection, has announced its participation in the upcoming Jefferies Global Healthcare Conference 2025. The company's management will deliver a presentation on Tuesday, June 4 at 11:40 a.m. ET in New York. Investors and interested parties can access both live and replay webcasts of the presentation through GRAIL's investor relations website at investors.grail.com. The webcast recording will remain available for a minimum of 30 days following the event.
GRAIL (NASDAQ: GRAL), un'azienda sanitaria specializzata nella diagnosi precoce del cancro, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference 2025. Il management dell'azienda terrà una presentazione martedì 4 giugno alle 11:40 ET a New York. Investitori e interessati potranno seguire la diretta streaming e le repliche della presentazione tramite il sito web delle relazioni con gli investitori di GRAIL all'indirizzo investors.grail.com. La registrazione del webcast resterà disponibile per almeno 30 giorni dopo l'evento.
GRAIL (NASDAQ: GRAL), una empresa de salud enfocada en la detección temprana del cáncer, ha anunciado su participación en la próxima Jefferies Global Healthcare Conference 2025. La dirección de la compañía realizará una presentación el martes 4 de junio a las 11:40 a.m. ET en Nueva York. Los inversores y personas interesadas podrán acceder a las transmisiones en vivo y a las repeticiones a través del sitio web de relaciones con inversores de GRAIL en investors.grail.com. La grabación del webcast estará disponible por un mínimo de 30 días después del evento.
GRAIL(나스닥: GRAL)는 조기 암 진단에 중점을 둔 헬스케어 기업으로, 다가오는 Jefferies Global Healthcare Conference 2025에 참여할 것이라고 발표했습니다. 회사 경영진은 6월 4일 화요일 오전 11시 40분(동부시간) 뉴욕에서 발표를 진행할 예정입니다. 투자자 및 관심 있는 분들은 GRAIL 투자자 관계 웹사이트 investors.grail.com을 통해 생중계 및 다시보기 웹캐스트를 시청할 수 있습니다. 웹캐스트 녹화는 행사 후 최소 30일간 제공됩니다.
GRAIL (NASDAQ : GRAL), une entreprise de santé spécialisée dans la détection précoce du cancer, a annoncé sa participation à la prochaine Jefferies Global Healthcare Conference 2025. La direction de la société présentera le mardi 4 juin à 11h40 ET à New York. Les investisseurs et les parties intéressées pourront accéder aux webcasts en direct et en replay via le site des relations investisseurs de GRAIL à l'adresse investors.grail.com. L'enregistrement du webcast restera disponible pendant au moins 30 jours après l'événement.
GRAIL (NASDAQ: GRAL), ein Gesundheitsunternehmen, das sich auf die frühzeitige Krebsdiagnose spezialisiert hat, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference 2025 angekündigt. Das Management des Unternehmens wird am Dienstag, den 4. Juni um 11:40 Uhr ET in New York eine Präsentation halten. Investoren und Interessierte können sowohl Live- als auch Wiederholungswebcasts der Präsentation über die Investor-Relations-Website von GRAIL unter investors.grail.com verfolgen. Die Aufzeichnung des Webcasts wird mindestens 30 Tage nach der Veranstaltung verfügbar bleiben.
- None.
- None.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-jefferies-global-healthcare-conference-2025-302462235.html
SOURCE GRAIL, Inc.
FAQ
When is GRAIL (GRAL) presenting at the Jefferies Global Healthcare Conference 2025?
How can investors watch GRAIL's (GRAL) presentation at the Jefferies Healthcare Conference?
How long will GRAIL's (GRAL) Jefferies Conference presentation replay be available?
What is GRAIL's (GRAL) main business focus?
